OBP Ondine Biomed

 
TIDMOBP 
 
Ondine Biopharma Corporation: AIM Notification 
FOR:  ONDINE BIOPHARMA CORPORATION 
 
TSX, AIM SYMBOL:  OBP 
 
April 13, 2010 
 
Ondine Biopharma Corporation: AIM Notification 
 
VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 13, 2010) - Ondine Biopharma Corporation (TSX:OBP)(AIM:OBP) 
("Ondine" or the "Company") today announces the following transaction by a Director of the Company: 
 
/T/ 
 
=-------------------------------------------------------------------------- 
Name                                                           Merrill Biel 
=-------------------------------------------------------------------------- 
Relationship to the Company                                        Director 
=-------------------------------------------------------------------------- 
Date the transaction was reported to the Company              April 9, 2010 
=-------------------------------------------------------------------------- 
Nature of the transaction                              Options issued which 
                                                      entitle the holder to 
                                                     purchase common shares 
                                                        under the Company's 
                                                          stock option plan 
=-------------------------------------------------------------------------- 
Grant date                                                    April 9, 2010 
=-------------------------------------------------------------------------- 
Expiry date                                                   April 9, 2015 
=-------------------------------------------------------------------------- 
Number of options issued                                            200,000 
=-------------------------------------------------------------------------- 
Exercise price per option, each option 
is exercisable into one common share                            Cdn. $0.075 
=-------------------------------------------------------------------------- 
Price per security issued in this transaction                           Nil 
=-------------------------------------------------------------------------- 
Nature and extent of the above's interest                       100% direct 
in the transaction                                       ownership interest 
=-------------------------------------------------------------------------- 
Close period                                                             No 
=-------------------------------------------------------------------------- 
Additional information                           The options vest in stages 
                                                      during the first year 
                                                    after the date of grant 
=-------------------------------------------------------------------------- 
 
/T/ 
 
-30- 
 
FOR FURTHER INFORMATION PLEASE CONTACT: 
 
Ondine Biopharma Corporation 
Carolyn Cross 
Chairman and CEO 
(604) 669-0555 
ccross@ondinebiopharma.com 
www.ondinebiopharma.com 
 
OR 
 
Canaccord Adams Ltd. 
Ryan Gaffney 
Nominated Adviser 
+4420 7050 6500 
 
 
 
 
Ondine Biopharma Corporation 
 

Ondine Biomed (LSE:OBP)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024

Ondine Biomed (LSE:OBP)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024